{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/abbvie-showcases-latebreaking-phase-2-data-for-mirvetuximab-soravtansine-gynx-elahere-in-platinumsensitive-ovarian-cancer-psoc-at-sgo-2026-302739847.html", "message": "News view counter 658981 successfully enlarged"}